January 25, 2013 12:34 PM IST

Biocon Plans to Introduce New Psoriasis Drug in July-Sept Quarter

Latest News in Economy

Biocon Plans to Introduce New Psoriasis Drug in July-Sept Quarter

Biocon(BION.NS), India's top listed biotech firm, plans to launch psoriasis drug Alzumab in the country in the July-September quarter, a top company executive said on Friday.

Kiran Mazumdar-Shaw, chairman and managing director of Biocon Ltd., speaks during a news conference in Bangalore March 8, 2007.

The company expects sales of 1 billion rupees from the drug over four years, Kiran Mazumdar-Shaw, chairman, Biocon said in a conference call.

Late on Thursday, Biocon reported an 8.24 percent rise in net profit to 920 million rupees for the Oct-Dec quarter compared with a year earlier.

Reuters/Jagadeesh Nv/Files
Kiran Mazumdar-Shaw, chairman and managing director of Biocon Ltd., speaks during a news conference in Bangalore March 8, 2007.
Copyright 2012 Thomson Reuters. All rights reserved.
Share

Join the Conversation